Distinct from our candidate-gene approach, the authors pursued an shRNA-based screen for synergistic interactions with EGFR inhibition and uncovered a similar role for TNKS inhibitors in NSCLC. This evidence concerns the gene TNKS and non-small cell lung carcinoma.